P4‐388: XANAMEM TM : A Novel 11B‐HSD1 Inhibitor with Potential to Provide Durable Symptomatic and Disease Modifying Benefits in Alzheimer’S Disease

Authors :: Jeffrey L. Cummings
Brian R. Walker
Scott P. Webster
Vincent Ruffles
Craig W. Ritchie
Jonathan R. Seckl
Colin L. Masters
Source :: Alzheimer's & Dementia. 12
Publication Year :: 2016
Publisher :: Wiley, 2016.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Disease
03 medical and health sciences
Psychiatry and Mental health
Cellular and Molecular Neuroscience
030104 developmental biology
Developmental Neuroscience
Internal medicine
medicine
Neurology (clinical)
Geriatrics and Gerontology
business

Full Text Access

Tools